Activities of Marina YANNAKOUDAKIS related to 2010/2153(INI)
Plenary speeches (1)
Management of H1N1 influenza (short presentation)
Shadow reports (1)
REPORT on evaluation of the management of H1N1 influenza in 2009-2010 in the EU PDF (194 KB) DOC (128 KB)
Amendments (18)
Amendment 16 #
Motion for a resolution
Recital B
Recital B
Amendment 27 #
Motion for a resolution
Recital B f (new)
Recital B f (new)
Bf. whereas Member States, the European Commission and external bodies such as WHO should take into account the virulence of a future influenza outbreak as well as the propagation of the virus when making public health decisions which may affect public health and social policies in Member States,
Amendment 29 #
Motion for a resolution
Recital C
Recital C
Amendment 35 #
Motion for a resolution
Recital D
Recital D
D. whereas the expenditure committed by thecertain Member States to the response plans drawn up is mainly in connection with the purchase of vast quantities of vaccines,
Amendment 42 #
Motion for a resolution
Recital E
Recital E
Amendment 50 #
Motion for a resolution
Recital E b (new)
Recital E b (new)
Eb. whereas in the event of a future influenza pandemic, more work needs to be done to improve the performance of influenza vaccines, especially for high risk groups and against drifted variants,
Amendment 59 #
Motion for a resolution
Recital G
Recital G
G. whereas Member States need to make significant changes are required to their current healthcare system in the EU and its Member Statess and need to co-ordinate better in preparing against epidemics, in order to achieve general public health objectives, as opposed to a purely pharmacological approach,
Amendment 63 #
Motion for a resolution
Recital I
Recital I
Amendment 77 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Calls for the prevention plans established in the EU and its Member States for future influenza pandemics to be revis-examined, to make them sufficiently autonomous and flexible to be adapted as swiftly as possible and on a case by case basis to the actual risk, based not least on the latest scientific information available;
Amendment 92 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Takes the view that the powersmandate of the European Centre for Disease Prevention and Control (ECDC) should be reinforced so that the EU hasinclude its own means of assessing the severity of infection risk, by establishing, if necessary, its own health alert scale independent of international organisations such as the WHO;
Amendment 105 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Calls for immediate clarifican investigations on the effectiveness of the influenza vaccination strategies recommended in the EU, given the weight of evidence casting doubt on their effectiveness, the absence of reliable data guaranteeing that effectiveness and the lingering uncertainties surrounding their benefit-risk profile;
Amendment 123 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Calls on the Commission to launch an audit review of the operation of the EMA and the ECDC, and of the overall cost of the management of H1N1 influenza in the EU;
Amendment 127 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Reminds tThe EMA of theas a regulatory requirement toshould make access available to all the documents relating to clinical trials, research protocols and the undesirable effects of the medicinal products evaluated by its experts, including the vaccines and anti-viral drugs recommended as a means of combating H1N1 influenza;
Amendment 133 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Considers the conflicts of interest apparent in the case of somealls for the declarations of interest of all experts who advise the European institutions to give rise tobe published to avoid suspicions of undue influence and to, which would undermine the overall credibility of the European health agencies and their recommendations; calls in particular for the EMA and ECDC to revise forthwith their current and future expert screening procedures to ensure complete transparency;
Amendment 142 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls for the publication of the names, roles and potential conflictdeclarations of interest of senior officials who are members of informal groups such as the EU's Health Security Committee, the Health Emergency Operational Facility (HEOF) and the ‘vaccines’ task force;
Amendment 144 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls for full liability for the quality, safety and effectivenessicacy of a medicinal product to rest with the manufacturer, bearing in mind the exceptional circumstances a pandemic constitutes;
Amendment 160 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. DemandEstablishes precise definition of the roles, duties, remits, limits, relations and responsibilities of the Commission, the ECDC, the EMA and the Member States and also of more informal entities such as the Health Security Committee, the HEOF and the ‘public health’ group, composed of senior officials able to intervene in the decision-making process regarding the management of a health crisis;
Amendment 164 #
Motion for a resolution
Paragraph 12
Paragraph 12